Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$1.04 - $322.5 $229,364 - $71.1 Million
220,543 New
220,543 $379,000
Q1 2022

May 13, 2022

SELL
$0.62 - $1.17 $505,953 - $954,783
-816,054 Closed
0 $0
Q4 2021

Feb 10, 2022

BUY
$1.09 - $1.89 $451,982 - $783,713
414,663 Added 103.31%
816,054 $889,000
Q3 2021

Nov 10, 2021

BUY
$1.44 - $2.73 $36,162 - $68,558
25,113 Added 6.67%
401,391 $731,000
Q2 2021

Aug 10, 2021

SELL
$2.63 - $3.67 $427,590 - $596,675
-162,582 Reduced 30.17%
376,278 $993,000
Q1 2021

May 10, 2021

BUY
$2.82 - $5.6 $1.33 Million - $2.65 Million
472,514 Added 712.2%
538,860 $1.94 Million
Q4 2020

Feb 10, 2021

SELL
$2.09 - $3.09 $289,454 - $427,949
-138,495 Reduced 67.61%
66,346 $167,000
Q3 2020

Nov 13, 2020

BUY
$2.39 - $3.43 $336,724 - $483,249
140,889 Added 220.3%
204,841 $516,000
Q2 2020

Aug 07, 2020

BUY
$2.2 - $3.71 $105,217 - $177,434
47,826 Added 296.58%
63,952 $210,000
Q1 2020

May 15, 2020

SELL
$1.9 - $4.98 $229,601 - $601,798
-120,843 Reduced 88.23%
16,126 $40,000
Q4 2019

Feb 10, 2020

SELL
$3.95 - $5.35 $985,611 - $1.33 Million
-249,522 Reduced 64.56%
136,969 $646,000
Q3 2019

Nov 14, 2019

BUY
$4.13 - $6.94 $758,647 - $1.27 Million
183,692 Added 90.58%
386,491 $1.65 Million
Q2 2019

Aug 09, 2019

SELL
$3.98 - $6.2 $25,921 - $40,380
-6,513 Reduced 3.11%
202,799 $1.18 Million
Q1 2019

May 15, 2019

BUY
$2.0 - $4.4 $418,624 - $920,972
209,312 New
209,312 $806,000

Others Institutions Holding TCRT

About Alaunos Therapeutics, Inc.


  • Ticker TCRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,182,000
  • Market Cap $443M
  • Description
  • Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...
More about TCRT
Track This Portfolio

Track Rafferty Asset Management, LLC Portfolio

Follow Rafferty Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.